InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: wwtmm post# 188891

Friday, 09/05/2014 11:45:30 AM

Friday, September 05, 2014 11:45:30 AM

Post# of 345953
I can agree with most of that and its places like Abbvie, CRI, UTSWM, Keystone Symposia, Japan...etc that are taking a big interest in PS Targeting - so keeping an eye on all affiliations surrounding places like these, and research that comes out of each just may help solve this puzzle of how Peregrine advances the, paradigm shifting, anti-PS Technology Platform.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News